nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ABCB1—Ethinyl Estradiol—osteoporosis	0.0771	0.203	CbGbCtD
Timolol—CYP2C19—Cholecalciferol—osteoporosis	0.0764	0.201	CbGbCtD
Timolol—CYP2C19—Estradiol—osteoporosis	0.0616	0.162	CbGbCtD
Timolol—CYP2D6—Cholecalciferol—osteoporosis	0.0581	0.153	CbGbCtD
Timolol—ABCB1—Conjugated Estrogens—osteoporosis	0.0566	0.149	CbGbCtD
Timolol—ABCB1—Estradiol—osteoporosis	0.0497	0.131	CbGbCtD
Timolol—Arthralgia—Zoledronate—osteoporosis	0.000431	0.000739	CcSEcCtD
Timolol—Chest pain—Zoledronate—osteoporosis	0.000431	0.000739	CcSEcCtD
Timolol—Myalgia—Zoledronate—osteoporosis	0.000431	0.000739	CcSEcCtD
Timolol—Palpitations—Conjugated Estrogens—osteoporosis	0.000431	0.000738	CcSEcCtD
Timolol—Insomnia—Risedronate—osteoporosis	0.000431	0.000738	CcSEcCtD
Timolol—Anxiety—Zoledronate—osteoporosis	0.00043	0.000736	CcSEcCtD
Timolol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000429	0.000734	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000428	0.000734	CcSEcCtD
Timolol—Paraesthesia—Risedronate—osteoporosis	0.000428	0.000732	CcSEcCtD
Timolol—Pruritus—Estropipate—osteoporosis	0.000426	0.00073	CcSEcCtD
Timolol—Discomfort—Zoledronate—osteoporosis	0.000426	0.00073	CcSEcCtD
Timolol—Asthenia—Alendronate—osteoporosis	0.000426	0.000729	CcSEcCtD
Timolol—Hypersensitivity—Ibandronate—osteoporosis	0.000426	0.000729	CcSEcCtD
Timolol—Cough—Conjugated Estrogens—osteoporosis	0.000426	0.000729	CcSEcCtD
Timolol—Dyspnoea—Risedronate—osteoporosis	0.000425	0.000727	CcSEcCtD
Timolol—Hypotension—Pamidronate—osteoporosis	0.000423	0.000724	CcSEcCtD
Timolol—Dry mouth—Zoledronate—osteoporosis	0.000422	0.000722	CcSEcCtD
Timolol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000422	0.000722	CcSEcCtD
Timolol—Fatigue—Ethinyl Estradiol—osteoporosis	0.000421	0.000721	CcSEcCtD
Timolol—Pruritus—Alendronate—osteoporosis	0.00042	0.000719	CcSEcCtD
Timolol—Dyspepsia—Risedronate—osteoporosis	0.000419	0.000718	CcSEcCtD
Timolol—Eye disorder—Estradiol—osteoporosis	0.000419	0.000718	CcSEcCtD
Timolol—Tinnitus—Estradiol—osteoporosis	0.000418	0.000716	CcSEcCtD
Timolol—Confusional state—Zoledronate—osteoporosis	0.000417	0.000714	CcSEcCtD
Timolol—Hypersensitivity—Calcitriol—osteoporosis	0.000417	0.000714	CcSEcCtD
Timolol—Cardiac disorder—Estradiol—osteoporosis	0.000416	0.000713	CcSEcCtD
Timolol—Chest pain—Conjugated Estrogens—osteoporosis	0.000415	0.000711	CcSEcCtD
Timolol—Arthralgia—Conjugated Estrogens—osteoporosis	0.000415	0.000711	CcSEcCtD
Timolol—Myalgia—Conjugated Estrogens—osteoporosis	0.000415	0.000711	CcSEcCtD
Timolol—Asthenia—Ibandronate—osteoporosis	0.000415	0.00071	CcSEcCtD
Timolol—Anxiety—Conjugated Estrogens—osteoporosis	0.000414	0.000709	CcSEcCtD
Timolol—Nausea—Etidronic acid—osteoporosis	0.000414	0.000709	CcSEcCtD
Timolol—Anaphylactic shock—Zoledronate—osteoporosis	0.000413	0.000708	CcSEcCtD
Timolol—Oedema—Zoledronate—osteoporosis	0.000413	0.000708	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000412	0.000706	CcSEcCtD
Timolol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000412	0.000706	CcSEcCtD
Timolol—Diarrhoea—Estropipate—osteoporosis	0.000412	0.000706	CcSEcCtD
Timolol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000411	0.000704	CcSEcCtD
Timolol—Infection—Zoledronate—osteoporosis	0.000411	0.000704	CcSEcCtD
Timolol—Fatigue—Risedronate—osteoporosis	0.000411	0.000703	CcSEcCtD
Timolol—Insomnia—Pamidronate—osteoporosis	0.000409	0.000701	CcSEcCtD
Timolol—Pruritus—Ibandronate—osteoporosis	0.000409	0.0007	CcSEcCtD
Timolol—Pain—Risedronate—osteoporosis	0.000407	0.000697	CcSEcCtD
Timolol—Angiopathy—Estradiol—osteoporosis	0.000407	0.000697	CcSEcCtD
Timolol—Shock—Zoledronate—osteoporosis	0.000407	0.000697	CcSEcCtD
Timolol—Paraesthesia—Pamidronate—osteoporosis	0.000406	0.000696	CcSEcCtD
Timolol—Diarrhoea—Alendronate—osteoporosis	0.000406	0.000695	CcSEcCtD
Timolol—Asthenia—Calcitriol—osteoporosis	0.000406	0.000695	CcSEcCtD
Timolol—Nervous system disorder—Zoledronate—osteoporosis	0.000405	0.000694	CcSEcCtD
Timolol—Immune system disorder—Estradiol—osteoporosis	0.000405	0.000694	CcSEcCtD
Timolol—Mediastinal disorder—Estradiol—osteoporosis	0.000404	0.000692	CcSEcCtD
Timolol—Dyspnoea—Pamidronate—osteoporosis	0.000404	0.000691	CcSEcCtD
Timolol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000402	0.000689	CcSEcCtD
Timolol—Somnolence—Pamidronate—osteoporosis	0.000402	0.000689	CcSEcCtD
Timolol—Skin disorder—Zoledronate—osteoporosis	0.000402	0.000688	CcSEcCtD
Timolol—Pruritus—Calcitriol—osteoporosis	0.0004	0.000685	CcSEcCtD
Timolol—Hyperhidrosis—Zoledronate—osteoporosis	0.0004	0.000685	CcSEcCtD
Timolol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000399	0.000684	CcSEcCtD
Timolol—Diarrhoea—Raloxifene—osteoporosis	0.000399	0.000684	CcSEcCtD
Timolol—Dyspepsia—Pamidronate—osteoporosis	0.000398	0.000682	CcSEcCtD
Timolol—Dizziness—Estropipate—osteoporosis	0.000398	0.000682	CcSEcCtD
Timolol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000398	0.000682	CcSEcCtD
Timolol—Oedema—Conjugated Estrogens—osteoporosis	0.000398	0.000682	CcSEcCtD
Timolol—Alopecia—Estradiol—osteoporosis	0.000396	0.000679	CcSEcCtD
Timolol—Infection—Conjugated Estrogens—osteoporosis	0.000396	0.000677	CcSEcCtD
Timolol—Diarrhoea—Ibandronate—osteoporosis	0.000395	0.000677	CcSEcCtD
Timolol—Anorexia—Zoledronate—osteoporosis	0.000394	0.000675	CcSEcCtD
Timolol—Decreased appetite—Pamidronate—osteoporosis	0.000393	0.000674	CcSEcCtD
Timolol—Mental disorder—Estradiol—osteoporosis	0.000393	0.000673	CcSEcCtD
Timolol—Dizziness—Alendronate—osteoporosis	0.000392	0.000672	CcSEcCtD
Timolol—Shock—Conjugated Estrogens—osteoporosis	0.000392	0.000671	CcSEcCtD
Timolol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000391	0.000669	CcSEcCtD
Timolol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00039	0.000669	CcSEcCtD
Timolol—Erythema—Estradiol—osteoporosis	0.00039	0.000669	CcSEcCtD
Timolol—Malnutrition—Estradiol—osteoporosis	0.00039	0.000669	CcSEcCtD
Timolol—Fatigue—Pamidronate—osteoporosis	0.00039	0.000668	CcSEcCtD
Timolol—Gastrointestinal pain—Risedronate—osteoporosis	0.000389	0.000667	CcSEcCtD
Timolol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000388	0.000664	CcSEcCtD
Timolol—Pain—Pamidronate—osteoporosis	0.000387	0.000663	CcSEcCtD
Timolol—Diarrhoea—Calcitriol—osteoporosis	0.000387	0.000663	CcSEcCtD
Timolol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000387	0.000662	CcSEcCtD
Timolol—Hypotension—Zoledronate—osteoporosis	0.000386	0.000662	CcSEcCtD
Timolol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000386	0.000661	CcSEcCtD
Timolol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000386	0.000661	CcSEcCtD
Timolol—Dizziness—Raloxifene—osteoporosis	0.000386	0.000661	CcSEcCtD
Timolol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000385	0.000659	CcSEcCtD
Timolol—Tension—Estradiol—osteoporosis	0.000383	0.000656	CcSEcCtD
Timolol—Vomiting—Estropipate—osteoporosis	0.000383	0.000656	CcSEcCtD
Timolol—Dysgeusia—Estradiol—osteoporosis	0.000382	0.000655	CcSEcCtD
Timolol—Dizziness—Ibandronate—osteoporosis	0.000382	0.000654	CcSEcCtD
Timolol—Rash—Estropipate—osteoporosis	0.00038	0.000651	CcSEcCtD
Timolol—Dermatitis—Estropipate—osteoporosis	0.00038	0.00065	CcSEcCtD
Timolol—Anorexia—Conjugated Estrogens—osteoporosis	0.000379	0.00065	CcSEcCtD
Timolol—Nervousness—Estradiol—osteoporosis	0.000379	0.000649	CcSEcCtD
Timolol—Urticaria—Risedronate—osteoporosis	0.000378	0.000648	CcSEcCtD
Timolol—Headache—Estropipate—osteoporosis	0.000377	0.000646	CcSEcCtD
Timolol—Vomiting—Alendronate—osteoporosis	0.000377	0.000646	CcSEcCtD
Timolol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000377	0.000645	CcSEcCtD
Timolol—Abdominal pain—Risedronate—osteoporosis	0.000376	0.000645	CcSEcCtD
Timolol—Body temperature increased—Risedronate—osteoporosis	0.000376	0.000645	CcSEcCtD
Timolol—Rash—Alendronate—osteoporosis	0.000374	0.000641	CcSEcCtD
Timolol—Insomnia—Zoledronate—osteoporosis	0.000374	0.00064	CcSEcCtD
Timolol—Dermatitis—Alendronate—osteoporosis	0.000374	0.00064	CcSEcCtD
Timolol—Feeling abnormal—Pamidronate—osteoporosis	0.000373	0.000639	CcSEcCtD
Timolol—Hypotension—Conjugated Estrogens—osteoporosis	0.000372	0.000637	CcSEcCtD
Timolol—Headache—Alendronate—osteoporosis	0.000372	0.000637	CcSEcCtD
Timolol—Paraesthesia—Zoledronate—osteoporosis	0.000371	0.000636	CcSEcCtD
Timolol—Vomiting—Raloxifene—osteoporosis	0.000371	0.000636	CcSEcCtD
Timolol—Gastrointestinal pain—Pamidronate—osteoporosis	0.00037	0.000634	CcSEcCtD
Timolol—Dyspnoea—Zoledronate—osteoporosis	0.000369	0.000631	CcSEcCtD
Timolol—Rash—Raloxifene—osteoporosis	0.000368	0.00063	CcSEcCtD
Timolol—Dermatitis—Raloxifene—osteoporosis	0.000368	0.00063	CcSEcCtD
Timolol—Somnolence—Zoledronate—osteoporosis	0.000368	0.00063	CcSEcCtD
Timolol—Vomiting—Ibandronate—osteoporosis	0.000367	0.000629	CcSEcCtD
Timolol—Headache—Raloxifene—osteoporosis	0.000366	0.000626	CcSEcCtD
Timolol—Rash—Ibandronate—osteoporosis	0.000364	0.000624	CcSEcCtD
Timolol—Dermatitis—Ibandronate—osteoporosis	0.000364	0.000623	CcSEcCtD
Timolol—Dyspepsia—Zoledronate—osteoporosis	0.000364	0.000623	CcSEcCtD
Timolol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000363	0.000621	CcSEcCtD
Timolol—Headache—Ibandronate—osteoporosis	0.000362	0.00062	CcSEcCtD
Timolol—Insomnia—Conjugated Estrogens—osteoporosis	0.00036	0.000617	CcSEcCtD
Timolol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00036	0.000616	CcSEcCtD
Timolol—Vomiting—Calcitriol—osteoporosis	0.00036	0.000616	CcSEcCtD
Timolol—Decreased appetite—Zoledronate—osteoporosis	0.000359	0.000616	CcSEcCtD
Timolol—Nausea—Estropipate—osteoporosis	0.000358	0.000613	CcSEcCtD
Timolol—Abdominal pain—Pamidronate—osteoporosis	0.000358	0.000613	CcSEcCtD
Timolol—Body temperature increased—Pamidronate—osteoporosis	0.000358	0.000613	CcSEcCtD
Timolol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000357	0.000612	CcSEcCtD
Timolol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000357	0.000611	CcSEcCtD
Timolol—Angioedema—Estradiol—osteoporosis	0.000357	0.000611	CcSEcCtD
Timolol—Rash—Calcitriol—osteoporosis	0.000357	0.000611	CcSEcCtD
Timolol—Fatigue—Zoledronate—osteoporosis	0.000356	0.000611	CcSEcCtD
Timolol—Dermatitis—Calcitriol—osteoporosis	0.000356	0.00061	CcSEcCtD
Timolol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000355	0.000608	CcSEcCtD
Timolol—Headache—Calcitriol—osteoporosis	0.000354	0.000607	CcSEcCtD
Timolol—Somnolence—Conjugated Estrogens—osteoporosis	0.000354	0.000606	CcSEcCtD
Timolol—Pain—Zoledronate—osteoporosis	0.000354	0.000606	CcSEcCtD
Timolol—Nausea—Alendronate—osteoporosis	0.000353	0.000604	CcSEcCtD
Timolol—Hypersensitivity—Risedronate—osteoporosis	0.000351	0.000601	CcSEcCtD
Timolol—Vertigo—Estradiol—osteoporosis	0.000351	0.000601	CcSEcCtD
Timolol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00035	0.0006	CcSEcCtD
Timolol—Asthenia—Ethinyl Estradiol—osteoporosis	0.00035	0.0006	CcSEcCtD
Timolol—Syncope—Estradiol—osteoporosis	0.00035	0.0006	CcSEcCtD
Timolol—Nausea—Raloxifene—osteoporosis	0.000347	0.000594	CcSEcCtD
Timolol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000346	0.000593	CcSEcCtD
Timolol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000346	0.000592	CcSEcCtD
Timolol—Palpitations—Estradiol—osteoporosis	0.000345	0.000591	CcSEcCtD
Timolol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000344	0.000589	CcSEcCtD
Timolol—Fatigue—Conjugated Estrogens—osteoporosis	0.000343	0.000588	CcSEcCtD
Timolol—Nausea—Ibandronate—osteoporosis	0.000343	0.000588	CcSEcCtD
Timolol—Loss of consciousness—Estradiol—osteoporosis	0.000343	0.000588	CcSEcCtD
Timolol—Asthenia—Risedronate—osteoporosis	0.000342	0.000585	CcSEcCtD
Timolol—Feeling abnormal—Zoledronate—osteoporosis	0.000341	0.000584	CcSEcCtD
Timolol—Cough—Estradiol—osteoporosis	0.000341	0.000583	CcSEcCtD
Timolol—Pain—Conjugated Estrogens—osteoporosis	0.00034	0.000583	CcSEcCtD
Timolol—Gastrointestinal pain—Zoledronate—osteoporosis	0.000338	0.000579	CcSEcCtD
Timolol—Hypertension—Estradiol—osteoporosis	0.000337	0.000577	CcSEcCtD
Timolol—Pruritus—Risedronate—osteoporosis	0.000337	0.000577	CcSEcCtD
Timolol—Nausea—Calcitriol—osteoporosis	0.000336	0.000575	CcSEcCtD
Timolol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000334	0.000572	CcSEcCtD
Timolol—Hypersensitivity—Pamidronate—osteoporosis	0.000333	0.000571	CcSEcCtD
Timolol—Myalgia—Estradiol—osteoporosis	0.000332	0.000569	CcSEcCtD
Timolol—Arthralgia—Estradiol—osteoporosis	0.000332	0.000569	CcSEcCtD
Timolol—Chest pain—Estradiol—osteoporosis	0.000332	0.000569	CcSEcCtD
Timolol—Anxiety—Estradiol—osteoporosis	0.000331	0.000567	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00033	0.000565	CcSEcCtD
Timolol—Urticaria—Zoledronate—osteoporosis	0.000328	0.000563	CcSEcCtD
Timolol—Discomfort—Estradiol—osteoporosis	0.000328	0.000562	CcSEcCtD
Timolol—Abdominal pain—Zoledronate—osteoporosis	0.000327	0.00056	CcSEcCtD
Timolol—Body temperature increased—Zoledronate—osteoporosis	0.000327	0.00056	CcSEcCtD
Timolol—Diarrhoea—Risedronate—osteoporosis	0.000326	0.000558	CcSEcCtD
Timolol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000326	0.000558	CcSEcCtD
Timolol—Dry mouth—Estradiol—osteoporosis	0.000325	0.000557	CcSEcCtD
Timolol—Asthenia—Pamidronate—osteoporosis	0.000325	0.000556	CcSEcCtD
Timolol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000323	0.000553	CcSEcCtD
Timolol—Confusional state—Estradiol—osteoporosis	0.000321	0.00055	CcSEcCtD
Timolol—Pruritus—Pamidronate—osteoporosis	0.00032	0.000548	CcSEcCtD
Timolol—Oedema—Estradiol—osteoporosis	0.000319	0.000546	CcSEcCtD
Timolol—Anaphylactic shock—Estradiol—osteoporosis	0.000319	0.000546	CcSEcCtD
Timolol—Infection—Estradiol—osteoporosis	0.000317	0.000542	CcSEcCtD
Timolol—Urticaria—Conjugated Estrogens—osteoporosis	0.000316	0.000542	CcSEcCtD
Timolol—Dizziness—Risedronate—osteoporosis	0.000315	0.000539	CcSEcCtD
Timolol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000315	0.000539	CcSEcCtD
Timolol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000315	0.000539	CcSEcCtD
Timolol—Shock—Estradiol—osteoporosis	0.000313	0.000537	CcSEcCtD
Timolol—Nervous system disorder—Estradiol—osteoporosis	0.000312	0.000535	CcSEcCtD
Timolol—Vomiting—Ethinyl Estradiol—osteoporosis	0.000311	0.000532	CcSEcCtD
Timolol—Diarrhoea—Pamidronate—osteoporosis	0.00031	0.00053	CcSEcCtD
Timolol—Skin disorder—Estradiol—osteoporosis	0.000309	0.00053	CcSEcCtD
Timolol—Hyperhidrosis—Estradiol—osteoporosis	0.000308	0.000528	CcSEcCtD
Timolol—Rash—Ethinyl Estradiol—osteoporosis	0.000308	0.000527	CcSEcCtD
Timolol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000308	0.000527	CcSEcCtD
Timolol—Headache—Ethinyl Estradiol—osteoporosis	0.000306	0.000524	CcSEcCtD
Timolol—Hypersensitivity—Zoledronate—osteoporosis	0.000305	0.000522	CcSEcCtD
Timolol—Vomiting—Risedronate—osteoporosis	0.000303	0.000519	CcSEcCtD
Timolol—Rash—Risedronate—osteoporosis	0.0003	0.000514	CcSEcCtD
Timolol—Dermatitis—Risedronate—osteoporosis	0.0003	0.000514	CcSEcCtD
Timolol—Dizziness—Pamidronate—osteoporosis	0.000299	0.000513	CcSEcCtD
Timolol—Headache—Risedronate—osteoporosis	0.000298	0.000511	CcSEcCtD
Timolol—Asthenia—Zoledronate—osteoporosis	0.000297	0.000508	CcSEcCtD
Timolol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000293	0.000502	CcSEcCtD
Timolol—Pruritus—Zoledronate—osteoporosis	0.000293	0.000501	CcSEcCtD
Timolol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00029	0.000497	CcSEcCtD
Timolol—Nausea—Ethinyl Estradiol—osteoporosis	0.00029	0.000497	CcSEcCtD
Timolol—Insomnia—Estradiol—osteoporosis	0.000288	0.000494	CcSEcCtD
Timolol—Vomiting—Pamidronate—osteoporosis	0.000288	0.000493	CcSEcCtD
Timolol—Paraesthesia—Estradiol—osteoporosis	0.000286	0.00049	CcSEcCtD
Timolol—Asthenia—Conjugated Estrogens—osteoporosis	0.000286	0.000489	CcSEcCtD
Timolol—Rash—Pamidronate—osteoporosis	0.000285	0.000489	CcSEcCtD
Timolol—Dermatitis—Pamidronate—osteoporosis	0.000285	0.000488	CcSEcCtD
Timolol—Dyspnoea—Estradiol—osteoporosis	0.000284	0.000487	CcSEcCtD
Timolol—Headache—Pamidronate—osteoporosis	0.000284	0.000486	CcSEcCtD
Timolol—Somnolence—Estradiol—osteoporosis	0.000283	0.000485	CcSEcCtD
Timolol—Diarrhoea—Zoledronate—osteoporosis	0.000283	0.000485	CcSEcCtD
Timolol—Nausea—Risedronate—osteoporosis	0.000283	0.000484	CcSEcCtD
Timolol—Pruritus—Conjugated Estrogens—osteoporosis	0.000282	0.000482	CcSEcCtD
Timolol—Dyspepsia—Estradiol—osteoporosis	0.00028	0.00048	CcSEcCtD
Timolol—Decreased appetite—Estradiol—osteoporosis	0.000277	0.000474	CcSEcCtD
Timolol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000275	0.000471	CcSEcCtD
Timolol—Fatigue—Estradiol—osteoporosis	0.000275	0.00047	CcSEcCtD
Timolol—Dizziness—Zoledronate—osteoporosis	0.000273	0.000468	CcSEcCtD
Timolol—Pain—Estradiol—osteoporosis	0.000272	0.000467	CcSEcCtD
Timolol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000272	0.000467	CcSEcCtD
Timolol—Nausea—Pamidronate—osteoporosis	0.000269	0.00046	CcSEcCtD
Timolol—Dizziness—Conjugated Estrogens—osteoporosis	0.000263	0.000451	CcSEcCtD
Timolol—Vomiting—Zoledronate—osteoporosis	0.000263	0.00045	CcSEcCtD
Timolol—Feeling abnormal—Estradiol—osteoporosis	0.000263	0.00045	CcSEcCtD
Timolol—Rash—Zoledronate—osteoporosis	0.000261	0.000446	CcSEcCtD
Timolol—Gastrointestinal pain—Estradiol—osteoporosis	0.000261	0.000446	CcSEcCtD
Timolol—Dermatitis—Zoledronate—osteoporosis	0.00026	0.000446	CcSEcCtD
Timolol—Headache—Zoledronate—osteoporosis	0.000259	0.000444	CcSEcCtD
Timolol—Vomiting—Conjugated Estrogens—osteoporosis	0.000253	0.000434	CcSEcCtD
Timolol—Urticaria—Estradiol—osteoporosis	0.000253	0.000434	CcSEcCtD
Timolol—Abdominal pain—Estradiol—osteoporosis	0.000252	0.000431	CcSEcCtD
Timolol—Body temperature increased—Estradiol—osteoporosis	0.000252	0.000431	CcSEcCtD
Timolol—Rash—Conjugated Estrogens—osteoporosis	0.000251	0.00043	CcSEcCtD
Timolol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000251	0.00043	CcSEcCtD
Timolol—Headache—Conjugated Estrogens—osteoporosis	0.000249	0.000427	CcSEcCtD
Timolol—Nausea—Zoledronate—osteoporosis	0.000246	0.000421	CcSEcCtD
Timolol—Nausea—Conjugated Estrogens—osteoporosis	0.000236	0.000405	CcSEcCtD
Timolol—Hypersensitivity—Estradiol—osteoporosis	0.000235	0.000402	CcSEcCtD
Timolol—Asthenia—Estradiol—osteoporosis	0.000229	0.000392	CcSEcCtD
Timolol—Pruritus—Estradiol—osteoporosis	0.000225	0.000386	CcSEcCtD
Timolol—Diarrhoea—Estradiol—osteoporosis	0.000218	0.000373	CcSEcCtD
Timolol—Dizziness—Estradiol—osteoporosis	0.000211	0.000361	CcSEcCtD
Timolol—Vomiting—Estradiol—osteoporosis	0.000203	0.000347	CcSEcCtD
Timolol—Rash—Estradiol—osteoporosis	0.000201	0.000344	CcSEcCtD
Timolol—Dermatitis—Estradiol—osteoporosis	0.000201	0.000344	CcSEcCtD
Timolol—Headache—Estradiol—osteoporosis	0.0002	0.000342	CcSEcCtD
Timolol—Nausea—Estradiol—osteoporosis	0.000189	0.000324	CcSEcCtD
Timolol—ADRB1—GPCR ligand binding—PTHLH—osteoporosis	9.79e-05	0.00268	CbGpPWpGaD
Timolol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.59e-05	0.00262	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—PTHLH—osteoporosis	9.58e-05	0.00262	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—WNT1—osteoporosis	9.36e-05	0.00256	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—PTHLH—osteoporosis	9.32e-05	0.00255	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—MGLL—osteoporosis	9.17e-05	0.00251	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MGLL—osteoporosis	9.13e-05	0.00249	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—MGLL—osteoporosis	8.97e-05	0.00245	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—LRP5—osteoporosis	8.91e-05	0.00244	CbGpPWpGaD
Timolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.82e-05	0.00241	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CALCA—osteoporosis	8.62e-05	0.00236	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—LRP6—osteoporosis	8.52e-05	0.00233	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	8.47e-05	0.00232	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PTHLH—osteoporosis	8.47e-05	0.00231	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CALCA—osteoporosis	8.43e-05	0.0023	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	8.38e-05	0.00229	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	8.36e-05	0.00228	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CALCA—osteoporosis	8.21e-05	0.00224	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.95e-05	0.00217	CbGpPWpGaD
Timolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	7.85e-05	0.00214	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	7.79e-05	0.00213	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.75e-05	0.00212	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	7.69e-05	0.0021	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—POMC—osteoporosis	7.6e-05	0.00208	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SOST—osteoporosis	7.54e-05	0.00206	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CALCA—osteoporosis	7.45e-05	0.00204	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SOST—osteoporosis	7.38e-05	0.00202	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TLN1—osteoporosis	7.19e-05	0.00197	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL1B—osteoporosis	6.87e-05	0.00188	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTH1R—osteoporosis	6.82e-05	0.00186	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CALCR—osteoporosis	6.82e-05	0.00186	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PTH—osteoporosis	6.68e-05	0.00183	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CALCR—osteoporosis	6.67e-05	0.00182	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTH1R—osteoporosis	6.67e-05	0.00182	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.58e-05	0.0018	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PTH—osteoporosis	6.53e-05	0.00179	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CNR2—osteoporosis	6.51e-05	0.00178	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CNR2—osteoporosis	6.37e-05	0.00174	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—P4HB—osteoporosis	6.2e-05	0.0017	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.19e-05	0.00169	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PTH—osteoporosis	6.06e-05	0.00166	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTH—osteoporosis	6.04e-05	0.00165	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PTH—osteoporosis	5.93e-05	0.00162	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RAP1A—osteoporosis	5.93e-05	0.00162	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.92e-05	0.00162	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CNR2—osteoporosis	5.91e-05	0.00162	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CNR2—osteoporosis	5.88e-05	0.00161	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—ADCY5—osteoporosis	5.84e-05	0.0016	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.79e-05	0.00158	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NFATC1—osteoporosis	5.79e-05	0.00158	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CNR2—osteoporosis	5.78e-05	0.00158	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—DKK1—osteoporosis	5.74e-05	0.00157	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—WNT1—osteoporosis	5.56e-05	0.00152	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PTHLH—osteoporosis	5.53e-05	0.00151	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—WNT1—osteoporosis	5.53e-05	0.00151	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—WNT1—osteoporosis	5.44e-05	0.00149	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MGLL—osteoporosis	5.42e-05	0.00148	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PTHLH—osteoporosis	5.41e-05	0.00148	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FGA—osteoporosis	5.38e-05	0.00147	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—TGFB1—osteoporosis	5.34e-05	0.00146	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—ADCY5—osteoporosis	5.3e-05	0.00145	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MGLL—osteoporosis	5.3e-05	0.00145	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LRP5—osteoporosis	5.29e-05	0.00145	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.27e-05	0.00144	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LRP5—osteoporosis	5.17e-05	0.00141	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—POMC—osteoporosis	5.09e-05	0.00139	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.08e-05	0.00139	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LRP6—osteoporosis	5.06e-05	0.00138	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PTHLH—osteoporosis	5.02e-05	0.00137	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTHLH—osteoporosis	5e-05	0.00137	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—BMP2—osteoporosis	5e-05	0.00137	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—TNF—osteoporosis	4.99e-05	0.00136	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LRP6—osteoporosis	4.95e-05	0.00135	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PTHLH—osteoporosis	4.92e-05	0.00134	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FGB—osteoporosis	4.89e-05	0.00134	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CALCA—osteoporosis	4.87e-05	0.00133	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PKM—osteoporosis	4.8e-05	0.00131	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—FDPS—osteoporosis	4.8e-05	0.00131	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CALCA—osteoporosis	4.77e-05	0.0013	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PSMA2—osteoporosis	4.72e-05	0.00129	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PSMA5—osteoporosis	4.72e-05	0.00129	CbGpPWpGaD
Timolol—ABCB1—Metabolism—FDPS—osteoporosis	4.69e-05	0.00128	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PKM—osteoporosis	4.69e-05	0.00128	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—POMC—osteoporosis	4.68e-05	0.00128	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GPD2—osteoporosis	4.55e-05	0.00124	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PGLS—osteoporosis	4.55e-05	0.00124	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—POMC—osteoporosis	4.51e-05	0.00123	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GPD2—osteoporosis	4.44e-05	0.00121	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PGLS—osteoporosis	4.44e-05	0.00121	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CALCA—osteoporosis	4.42e-05	0.00121	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PKM—osteoporosis	4.42e-05	0.00121	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—FDPS—osteoporosis	4.42e-05	0.00121	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—POMC—osteoporosis	4.41e-05	0.00121	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CALCA—osteoporosis	4.4e-05	0.0012	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.4e-05	0.0012	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CALCA—osteoporosis	4.33e-05	0.00118	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—POMC—osteoporosis	4.29e-05	0.00117	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TLN1—osteoporosis	4.27e-05	0.00117	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PGLS—osteoporosis	4.19e-05	0.00114	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GPD2—osteoporosis	4.19e-05	0.00114	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TLN1—osteoporosis	4.18e-05	0.00114	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ATIC—osteoporosis	4.16e-05	0.00114	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PNP—osteoporosis	4.16e-05	0.00114	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ATIC—osteoporosis	4.06e-05	0.00111	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PNP—osteoporosis	4.06e-05	0.00111	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KL—osteoporosis	4e-05	0.00109	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—POMC—osteoporosis	3.9e-05	0.00107	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ATIC—osteoporosis	3.83e-05	0.00105	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PNP—osteoporosis	3.83e-05	0.00105	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6R—osteoporosis	3.8e-05	0.00104	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—P4HB—osteoporosis	3.68e-05	0.00101	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—P4HB—osteoporosis	3.6e-05	0.000985	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTH—osteoporosis	3.58e-05	0.000979	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CA2—osteoporosis	3.54e-05	0.000968	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—OXCT1—osteoporosis	3.54e-05	0.000968	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAP1A—osteoporosis	3.52e-05	0.000962	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTH—osteoporosis	3.5e-05	0.000958	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CNR2—osteoporosis	3.49e-05	0.000954	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—ADCY5—osteoporosis	3.47e-05	0.000947	CbGpPWpGaD
Timolol—ABCB1—Metabolism—OXCT1—osteoporosis	3.46e-05	0.000945	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CA2—osteoporosis	3.46e-05	0.000945	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MGLL—osteoporosis	3.45e-05	0.000943	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAP1A—osteoporosis	3.44e-05	0.000941	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFATC1—osteoporosis	3.43e-05	0.000939	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CNR2—osteoporosis	3.41e-05	0.000933	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—DKK1—osteoporosis	3.41e-05	0.000931	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—ADCY5—osteoporosis	3.39e-05	0.000927	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MGLL—osteoporosis	3.37e-05	0.000921	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFATC1—osteoporosis	3.36e-05	0.000918	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—DKK1—osteoporosis	3.33e-05	0.000911	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—WNT1—osteoporosis	3.28e-05	0.000897	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—OXCT1—osteoporosis	3.26e-05	0.00089	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CA2—osteoporosis	3.26e-05	0.00089	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.25e-05	0.000889	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—WNT1—osteoporosis	3.21e-05	0.000878	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGA—osteoporosis	3.19e-05	0.000873	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MGLL—osteoporosis	3.17e-05	0.000868	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	3.15e-05	0.00086	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ADCY5—osteoporosis	3.13e-05	0.000856	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGA—osteoporosis	3.12e-05	0.000854	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	3.08e-05	0.000841	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SPP1—osteoporosis	3.03e-05	0.000828	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTHLH—osteoporosis	2.97e-05	0.000811	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BMP2—osteoporosis	2.97e-05	0.000811	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—IDH2—osteoporosis	2.93e-05	0.000802	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGB—osteoporosis	2.9e-05	0.000794	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTHLH—osteoporosis	2.9e-05	0.000794	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BMP2—osteoporosis	2.9e-05	0.000794	CbGpPWpGaD
Timolol—ABCB1—Metabolism—IDH2—osteoporosis	2.86e-05	0.000783	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGB—osteoporosis	2.84e-05	0.000777	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PSMA5—osteoporosis	2.8e-05	0.000766	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PSMA2—osteoporosis	2.8e-05	0.000766	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.76e-05	0.000754	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PSMA5—osteoporosis	2.74e-05	0.00075	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PSMA2—osteoporosis	2.74e-05	0.00075	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IRS2—osteoporosis	2.74e-05	0.000749	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—IDH2—osteoporosis	2.7e-05	0.000738	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP27A1—osteoporosis	2.69e-05	0.000736	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ACP5—osteoporosis	2.68e-05	0.000734	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—LEP—osteoporosis	2.68e-05	0.000733	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.65e-05	0.000724	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.64e-05	0.000722	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.64e-05	0.00072	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ACP5—osteoporosis	2.62e-05	0.000716	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CALCA—osteoporosis	2.61e-05	0.000714	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ESR1—osteoporosis	2.56e-05	0.0007	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CALCA—osteoporosis	2.56e-05	0.000699	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—POMC—osteoporosis	2.55e-05	0.000697	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.54e-05	0.000694	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TPI1—osteoporosis	2.49e-05	0.000682	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—POMC—osteoporosis	2.49e-05	0.000681	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ACP5—osteoporosis	2.47e-05	0.000675	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.47e-05	0.000674	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.46e-05	0.000673	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TPI1—osteoporosis	2.44e-05	0.000666	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IRS1—osteoporosis	2.39e-05	0.000654	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KL—osteoporosis	2.37e-05	0.000649	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—P4HB—osteoporosis	2.35e-05	0.000641	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KL—osteoporosis	2.32e-05	0.000634	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—POMC—osteoporosis	2.31e-05	0.000633	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—POMC—osteoporosis	2.3e-05	0.00063	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GAPDH—osteoporosis	2.3e-05	0.000629	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TPI1—osteoporosis	2.29e-05	0.000627	CbGpPWpGaD
Timolol—ABCB1—Metabolism—P4HB—osteoporosis	2.29e-05	0.000626	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—POMC—osteoporosis	2.26e-05	0.000619	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6R—osteoporosis	2.26e-05	0.000617	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GAPDH—osteoporosis	2.25e-05	0.000614	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6R—osteoporosis	2.25e-05	0.000614	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—RAP1A—osteoporosis	2.24e-05	0.000613	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IGF1—osteoporosis	2.22e-05	0.000606	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6R—osteoporosis	2.21e-05	0.000604	CbGpPWpGaD
Timolol—ABCB1—Metabolism—RAP1A—osteoporosis	2.19e-05	0.000598	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—P4HB—osteoporosis	2.16e-05	0.00059	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GAPDH—osteoporosis	2.12e-05	0.000579	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—RAP1A—osteoporosis	2.06e-05	0.000564	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.96e-05	0.000535	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADCY5—osteoporosis	1.86e-05	0.000508	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADCY5—osteoporosis	1.82e-05	0.000497	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ENO1—osteoporosis	1.81e-05	0.000495	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SPP1—osteoporosis	1.8e-05	0.000492	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PSMA5—osteoporosis	1.79e-05	0.000488	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PSMA2—osteoporosis	1.79e-05	0.000488	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ENO1—osteoporosis	1.77e-05	0.000484	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.76e-05	0.000481	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PSMA2—osteoporosis	1.74e-05	0.000477	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PSMA5—osteoporosis	1.74e-05	0.000477	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—osteoporosis	1.69e-05	0.000463	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ENO1—osteoporosis	1.67e-05	0.000456	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PSMA2—osteoporosis	1.64e-05	0.000449	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PSMA5—osteoporosis	1.64e-05	0.000449	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.63e-05	0.000445	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LEP—osteoporosis	1.59e-05	0.000435	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IRS2—osteoporosis	1.59e-05	0.000435	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LEP—osteoporosis	1.56e-05	0.000426	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.52e-05	0.000415	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ESR1—osteoporosis	1.49e-05	0.000406	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.45e-05	0.000396	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.42e-05	0.000388	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP19A1—osteoporosis	1.41e-05	0.000387	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IRS1—osteoporosis	1.39e-05	0.00038	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—POMC—osteoporosis	1.37e-05	0.000374	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—POMC—osteoporosis	1.34e-05	0.000366	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.33e-05	0.000365	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.33e-05	0.000364	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—osteoporosis	1.33e-05	0.000364	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—osteoporosis	1.33e-05	0.000363	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1—osteoporosis	1.32e-05	0.000359	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6R—osteoporosis	1.3e-05	0.000357	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1—osteoporosis	1.29e-05	0.000352	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ADCY5—osteoporosis	1.18e-05	0.000324	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GPX1—osteoporosis	1.18e-05	0.000323	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ADCY5—osteoporosis	1.16e-05	0.000316	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GPX1—osteoporosis	1.15e-05	0.000315	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADCY5—osteoporosis	1.09e-05	0.000298	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—osteoporosis	1.09e-05	0.000298	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GPX1—osteoporosis	1.09e-05	0.000297	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—osteoporosis	1.06e-05	0.000291	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—osteoporosis	1.01e-05	0.000275	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—osteoporosis	1e-05	0.000274	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—osteoporosis	1e-05	0.000274	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—osteoporosis	9.84e-06	0.000269	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—POMC—osteoporosis	8.71e-06	0.000238	CbGpPWpGaD
Timolol—ABCB1—Metabolism—POMC—osteoporosis	8.5e-06	0.000232	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—POMC—osteoporosis	8.01e-06	0.000219	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—osteoporosis	7.9e-06	0.000216	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—osteoporosis	7.88e-06	0.000216	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—osteoporosis	7.73e-06	0.000211	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—osteoporosis	7.71e-06	0.000211	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—osteoporosis	5.94e-06	0.000162	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—osteoporosis	5.81e-06	0.000159	CbGpPWpGaD
